|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/70 | (2006.01) |
| A61K 9/7069 | (2013.01) | ||
| A61K 31/341 | (2006.01) | ||
| A61K 31/341 | (2013.01) | ||
| A61K 31/4468 | (2006.01) | ||
| A61K 31/00 | (2013.01) | ||
| A61K 31/485 | (2006.01) | ||
| A61K 31/4468 | (2013.01) | ||
| C07D 489/08 | (2006.01) | ||
| C07D 489/08 | (2013.01) | ||
| A61K 31/485 | (2013.01) |
| (11) | Patento numeris | 3197275 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15844034.7 |
| Europos patento paraiškos padavimo data | 2015-09-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-11-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/051849 |
| Data | 2015-09-24 |
| (87) | Numeris | WO 2016/049266 |
| Data | 2016-03-31 |
| (30) | Numeris | Data | Šalis |
| 201462054515 P | 2014-09-24 | US | |
| 201562200309 P | 2015-08-03 | US |
| (72) |
BARBIER, Remi , US
FRIEDMANN, Nadav , US
SRIRAMBHATLA, Vijay , GB
WATT, Stephen , GB
ZAMLOOT, Michael , US
|
| (73) |
Pain Therapeutics, Inc. ,
7801 N Capital of Texas Highway, Suite 260, Austin TX 78731,
US
|
| (54) | 4:3 NALTREXONE: 5-METHYL-2-FURALDEHYDE COCRYSTAL |
| 4:3 NALTREXONE: 5-METHYL-2-FURALDEHYDE COCRYSTAL |